VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packa...
FDA Drug Recall #D-0241-2017 - Class III, December 12, 2016
Recall Summary
| Recall Number | D-0241-2017 |
| Classification | Class III, Low risk |
| Date Initiated | December 12, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | VIRTUS PHARMACEUTICALS OPCO II L |
| Location | Nashville, TN |
| Product Type | Drugs |
| Quantity | 124,250 bottles |
Product Description
VirtPrex Prenatal/Postnatal Tablets, Prescription Supplement Containing Folic Acid and DHA, packaged in 30-count bottle, Rx only, Made in Canada, NDC 76439-348-30
Reason for Recall
cGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.
Distribution Pattern
Nationwide
Lot / Code Information
Lots #: 21506124 Exp. Date 5/30/2017, 21511151 Exp. date 10/30/2017, 21511151A Exp. Data 10/30/2017, 21512163 Exp. date 11/30/2017, 21512164 Exp. date 11/30/2017
Other Recalls from VIRTUS PHARMACEUTICALS OPCO II L
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0240-2017 | Class III | Virt-Select Prenatal/Postnatal Softgels, Prescr... | Dec 12, 2016 |
| D-0239-2017 | Class III | Extra-Virt Plus DHA Prenatal/Postnatal Softgel,... | Dec 12, 2016 |
| D-0238-2017 | Class III | Virt-Advance Prenatal/Postnatal Softgels, Presc... | Dec 12, 2016 |
| D-0213-2017 | Class I | Hyoscyamine Sulfate, Orally Disintegrating Tabl... | Sep 2, 2016 |
| D-0212-2017 | Class I | Hyoscyamine Sulfate, Sublingual Tablets, 0.125 ... | Sep 2, 2016 |
Frequently Asked Questions
cGMP stands for Current Good Manufacturing Practice, the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful, in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications, even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications, use a drug take-back program.